Cellectar Biosciences, Inc. Quarterly Debt-to-equity in % from Q3 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Cellectar Biosciences, Inc. quarterly Debt-to-equity history and growth rate from Q3 2012 to Q2 2024.
  • Cellectar Biosciences, Inc. Debt-to-equity for the quarter ending June 30, 2024 was -552 %, a 247% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 -552 -928 -247% Jun 30, 2024
Q1 2024 -253 -352 -355% Mar 31, 2024
Q4 2023 -163 -219 -394% Dec 31, 2023
Q3 2023 -253 -285 -906% Sep 30, 2023
Q2 2023 377 +357 +1794% Jun 30, 2023
Q1 2023 99.2 +85.3 +613% Mar 31, 2023
Q4 2022 55.5 +45.3 +441% Dec 31, 2022
Q3 2022 31.4 +22.7 +261% Sep 30, 2022
Q2 2022 19.9 +9.33 +88.5% Jun 30, 2022
Q1 2022 13.9 +1.49 +12% Mar 31, 2022
Q4 2021 10.3 -5.99 -36.8% Dec 31, 2021
Q3 2021 8.7 -21 -70.7% Sep 30, 2021
Q2 2021 10.6 -19.4 -64.8% Jun 30, 2021
Q1 2021 12.4 -18.7 -60% Mar 31, 2021
Q4 2020 16.3 -10.2 -38.6% Dec 31, 2020
Q3 2020 29.7 +8.07 +37.4% Sep 30, 2020
Q2 2020 29.9 +11.5 +62.6% Jun 30, 2020
Q1 2020 31.1 +9.94 +47% Mar 31, 2020
Q4 2019 26.5 +5.54 +26.5% Dec 31, 2019
Q3 2019 21.6 -1.49 -6.46% Sep 30, 2019
Q2 2019 18.4 -10.4 -36.1% Jun 30, 2019
Q1 2019 21.1 -1.35 -6.01% Mar 31, 2019
Q4 2018 20.9 +3.05 +17.1% Dec 31, 2018
Q3 2018 23.1 +7 +43.6% Sep 30, 2018
Q2 2018 28.8 +14.3 +98.9% Jun 30, 2018
Q1 2018 22.5 +8.07 +56% Mar 31, 2018
Q4 2017 17.9 -5.61 -23.9% Dec 31, 2017
Q3 2017 16.1 -39.4 -71% Sep 30, 2017
Q2 2017 14.5 -95.9 -86.9% Jun 30, 2017
Q1 2017 14.4 -273 -95% Mar 31, 2017
Q4 2016 23.5 -238 -91% Dec 31, 2016
Q3 2016 55.4 -119 -68.2% Sep 30, 2016
Q2 2016 110 +3.78 +3.55% Jun 30, 2016
Q1 2016 287 +141 +96% Mar 31, 2016
Q4 2015 261 +37.4 +16.7% Dec 31, 2015
Q3 2015 175 -164 -48.5% Sep 30, 2015
Q2 2015 107 -857 -88.9% Jun 30, 2015
Q1 2015 147 -91.1 -38.3% Mar 31, 2015
Q4 2014 224 +94.3 +72.8% Dec 31, 2014
Q3 2014 339 +264 +351% Sep 30, 2014
Q2 2014 963 +912 +1756% Jun 30, 2014
Q1 2014 238 +208 +697% Mar 31, 2014
Q4 2013 129 +116 +879% Dec 31, 2013
Q3 2013 75.1 +62.3 +486% Sep 30, 2013
Q2 2013 51.9 Jun 30, 2013
Q1 2013 29.9 Mar 31, 2013
Q4 2012 13.2 Dec 31, 2012
Q3 2012 12.8 Sep 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.